1. Home
  2. LITE vs AXSM Comparison

LITE vs AXSM Comparison

Compare LITE & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITE
  • AXSM
  • Stock Information
  • Founded
  • LITE 2015
  • AXSM 2012
  • Country
  • LITE United States
  • AXSM United States
  • Employees
  • LITE N/A
  • AXSM N/A
  • Industry
  • LITE Telecommunications Equipment
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LITE Telecommunications
  • AXSM Health Care
  • Exchange
  • LITE Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • LITE 5.7B
  • AXSM 4.2B
  • IPO Year
  • LITE N/A
  • AXSM 2015
  • Fundamental
  • Price
  • LITE $85.08
  • AXSM $84.60
  • Analyst Decision
  • LITE Buy
  • AXSM Strong Buy
  • Analyst Count
  • LITE 14
  • AXSM 14
  • Target Price
  • LITE $77.86
  • AXSM $125.54
  • AVG Volume (30 Days)
  • LITE 1.4M
  • AXSM 893.5K
  • Earning Date
  • LITE 02-06-2025
  • AXSM 02-18-2025
  • Dividend Yield
  • LITE N/A
  • AXSM N/A
  • EPS Growth
  • LITE N/A
  • AXSM N/A
  • EPS
  • LITE N/A
  • AXSM N/A
  • Revenue
  • LITE $1,378,500,000.00
  • AXSM $338,457,000.00
  • Revenue This Year
  • LITE $19.19
  • AXSM $44.77
  • Revenue Next Year
  • LITE $28.40
  • AXSM $67.70
  • P/E Ratio
  • LITE N/A
  • AXSM N/A
  • Revenue Growth
  • LITE N/A
  • AXSM 51.47
  • 52 Week Low
  • LITE $38.29
  • AXSM $64.11
  • 52 Week High
  • LITE $96.25
  • AXSM $105.00
  • Technical
  • Relative Strength Index (RSI)
  • LITE 49.17
  • AXSM 43.66
  • Support Level
  • LITE $80.00
  • AXSM $79.19
  • Resistance Level
  • LITE $92.76
  • AXSM $87.53
  • Average True Range (ATR)
  • LITE 3.36
  • AXSM 4.37
  • MACD
  • LITE -0.45
  • AXSM -0.02
  • Stochastic Oscillator
  • LITE 39.81
  • AXSM 61.27

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: